MEI Pharma is an oncology company that focuses on the clinical development of novel therapies for cancer.
Business Model:
Revenue: $40.7M
Employees: 51-200
Address: 11455 El Camino Real
City: San Diego
State: CA
Zip: 92130
Country: US
MEI Pharma is an oncology company that focuses on the clinical development of novel therapies for cancer.
Contact Phone:
+18583697100
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/19/2003
Ticker Symbol:
MEIP
IPO Price:
$7.5/share
Amount Raised:
$16M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2003 | IPO | $15.6M |
|
11/2012 | Post-IPO Equity | 4 | $27.5M |
RA Capital Management Vivo Capital New Leaf Venture Partners Vivo Capital Three Arch Partners RA Capital Management Vivo Capital New Leaf Venture Partners Vivo Capital |
12/2021 | Post-IPO Equity | $49.2M | 5/2018 | Private Placement | $75M | 5/2018 | Post-IPO Equity | 7 | $75M |
CAM Capital Vivo Capital New Enterprise Associates Biotechnology Value Fund Perceptive Advisors Boxer Capital Amzak Health Investors CAM Capital Vivo Capital CAM Capital Vivo Capital New Enterprise Associates Biotechnology Value Fund Perceptive Advisors Boxer Capital Amzak Health Investors CAM Capital Vivo Capital |
12/2019 | Post-IPO Equity | $51.8M | 5/2011 | Post-IPO Equity | $1.1M | 7/2016 | Post-IPO Equity | 1 | $5M |
3B Future Health Fund 3B Future Health Fund |
12/2012 | Private Placement | $27.5M |
---|
Announced Date | Name | Price |
---|---|---|
2/2023 | Infinity Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|